SG Americas Securities’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
BCM
GCM
TAM
GLAM
CM
SUT
SG Americas Securities's CELL Position: Q3 2023 in Review
SG Americas Securities sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 45,387 shares — an estimated $22K sold.
SG Americas Securities first reported a position in CELL in Q3 2021 and held it in 8 quarters. The position peaked at $758K in Q2 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.
- SG Americas Securities reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- SG Americas Securities sold 45,387 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $22K.
- SG Americas Securities first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 8 quarters.
- SG Americas Securities's PhenomeX Inc. Common Stock position peaked at $758K in Q2 2022.
- 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.
Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.